NEW YORK (GenomeWeb) – NantOmics announced today it has acquired the remaining shares of OncoPlex Diagnostics that it didn't already own. 

The terms of the deal were not disclosed. 

NantOmics is a molecular diagnostics firm and part of the NantWorks network of firms founded by Patrick Soon-Shion. His companies have funded OncoPlex since 2008, NantOmics said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.